Skip to main content

Table 1 Clinical characteristics of 241 HCC patients underwent hepatectomy

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

Variables Training cohort (n = 211) Internal validation cohort (n = 30)
Age (years) 50.0 ± 11.4 50.0 ± 13.1
Gender, M: F 200:11 26:4
HBsAg   
 Positive 203 (96.2%) 28 (93.3%)
 Negative 8 (3.8%) 2 (6.7%)
AFP (ng/ml) 380.4 ± 519.4 326.3 ± 455.2
Platelet count (109/L) 175.3 ± 78.8 202.3 ± 86.6
Prothrombin time (s) 13.6 ± 1.3 13.5 ± 1.3
Total bilirubin (μmol/L) 17.6 ± 13.2 14.7 ± 9.4
Albumin (g/L) 39.8 ± 4.4 39.6 ± 4.8
Alanine aminotransferase (U/L) 48.6 ± 42.7 48.9 ± 28.7
Child–Pugh score   
 A 210 (99.5%) 28 (93.3%)
 B 1 (0.5%) 2 (6.7%)
  1. AFP alpha-fetoprotein, HCC hepatocellular carcinoma